Advanced search
Start date
Betweenand

Luis Carlos de Souza Ferreira

CV Lattes ORCID


Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB)  (Institutional affiliation from the last research proposal)
Birthplace: Brazil

He holds a degree in Biological Sciences from the Federal University of Rio de Janeiro (1978), a Master's degree in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro (1982) and a PhD in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro (1985). ). He carried out postdoctoral internships at the Max-Planck Institute in Tuebingen, Germany (1986/7), Center for Vaccine Development at the University of Maryland, USA (1991), Department of Microbiology and Molecular Biology at Tufts University, USA (1992 ) and Department of Medical Microbiology at the University of Gothenburg, Sweden (1996). Visiting Researcher at the Institute of Genetics at the University of Bayreuth, Germany (2000-2005). Adjunct Professor at the Department of Biophysics and Radiobiology at the Federal University of Pernambuco (1983-1989) and at the Carlos Chagas Filho Institute of Biophysics at the Federal University of Rio de Janeiro (1989-2000). He is currently a professor (1999) and full professor (2000) at the University of São Paulo and responsible for the Vaccine Development Laboratory at the Department of Microbiology at the Institute of Biomedical Sciences. Researcher 1A of the National Council for Scientific and Technological Development. Director of the Institute of Biomedical Sciences at USP (2017-2021). Coordinator of the Pasteur-USP Scientific Platform (2018-2023). President of the Deliberative Council of the USP/IPEN business incubator (CIETEC), member of the Health and Biotechnology Productive Chain Committee (Comsaude) of FIESP. He received several awards related to scientific work and technological innovation. He encouraged and participated in the creation of two USP spinoff companies. He has experience in the areas of Microbiology, Molecular and Microorganism Genetics, immunology, serological diagnostic methods and vaccine development. He develops different vaccine technologies, such as mucosal vaccines, subunit vaccines, vaccines with attenuated and vectorized microorganisms, genetic vaccines (DNA and mRNA), polyepitope vaccines and protein vaccine adjuvants. Developed vaccine formulations aimed at controlling diarrhea caused by enteric bacteria (diarrheogenic Escherichia coli and Salmonella), dengue virus, Zika, chikungunya, coronavirus, Streptococcus mutans and S. agalactiae, paracoccidioid mycosis, malaria and tumors induced by papilloma virus. He has published around 220 scientific articles in specialized journals. He has patents granted in Brazil and the USA. (Source: Lattes Curriculum)

Articles published in Pesquisa FAPESP Magazine about the researcher:
Surge una posible vacuna contra el cáncer causado por el VPH 
Vaccine candidate designed to treat cancer caused by HPV 
Standing alone 
Para caminar por sus propios medios 
Avanza el coronavirus en Brasil 
A villain with many faces 
Un villano con muchas caras 
A villain with many faces 
Articles published in Pesquisa para Inovação FAPESP about the researcher:
FAPESP-funded startups are developing COVID-19 vaccines  
News published in Agência FAPESP Newsletter about the researcher
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)
Research grants
Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers * Updated April 20, 2024
Total / Available in English
Most frequent collaborators in research granted by FAPESP
Contact researcher

Service temporarily unavailable

Keywords used by the researcher
Patent applications

SEQUENCIAS DE AMINOÁCIDOS DE PROTEÍNAS IMUNOGÊNICAS DETOXIFICADAS, PLASMÍDEO RECOMBINANTE, FORMULAÇÕES FARMACÊUTICAS E/OU VETERINÁRIAS CONTENDO O DERIVADO DA TOXINA TERMO-LÁBIL (LTK4R) E SEUS USOS PI1003740-3 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Universidade de São Paulo (USP). Luiz Carlos de Souza Ferreira ; Juliana Falcão Rodrigues ; Camila Mathias dos Santos ; Jaime Henrique Amorim - March 2010, 15

PROTEÍNA HÍBRIDA, SEQUÊNCIA DE ÁCIDOS NUCLÉICOS RECOMBINANTE, VETORES/PLASMÍDEOS, FORMULAÇÕES FARMACÊUTICAS E/OU VETERINÁRIAS E SEUS USOS NO CONTROLE DE TUMORES INDUZIDOS PELO VÍRUS DO PAPILOMA HUMANO E/OU DOENÇAS INFECCIOSAS OU DEGENERATIVAS PI1003749-7 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Universidade de São Paulo (USP). Luiz Carlos de Souza Ferreira ; Bruna Felicio M. M. Porchia ; Mariana de Oliveira Diniz ; Francisco Andre M. de O.Cariri ; Vinicius Canato Santana - August 2010, 18

SEQUÊNCIA DE ÁCIDO NUCLÉICO RECOMBINANTE QUE CODIFICA PARA OS AMINOÁCIDOS 39 A 512 DA PROTEÍNA P1 DO S. MUTANS, PROTEÍNA RECOMBINANTE E SEUS USOS NA PREVENÇÃO E CONTROLE DA CÁRIE DENTAL PI1103672-9 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Universidade de São Paulo (USP). Luís Carlos de Souza Ferreira ; Rita de Cássia Café Ferreira ; Wilson Barros Luiz ; Milene Tavares Batista ; Renata Damásio de Souza ; Rafael Ciro Marques Cavalcante - March 2011, 10

ESPOROS DE BACILLUS SP., MÉTODO DE PREPARO DOS ESPOROS, MÉTODO DE PREPARO DE CARTUCHOS DE BIOBALiSTICA, E USOS DOS ESPOROS BR1020140096795 - Universidade de São Paulo (USP). Julio Kravcuks Rozenfeld ; Luana Raposo de Moraes Aps ; Luis Calos de Souza Ferreira ; Maria Teresa Moura Maly ; Mariana de Oliveira Diniz ; Milene Tavares Batista - April 2014, 23

SEQUÊNCIA DE ÁCIDO NUCLEICO, ANTÍGENO RECOMBINANTE, KITS DE DIAGNÓSTICO, E USOS DOS MESMOS BR1020160113180 - Universidade de São Paulo (USP). Luís Carlos De Souza Ferreira ; Rúbens Prince Dos Santos Alves ; Lennon Ramos Pereira ; Robert Andreata Santos - May 2016, 18

Please report errors in researcher information using this form.
X

Report errors in this page


Error details: